The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
Related Posts
Trump’s tax cuts are ‘stuck in the mud’ as Republicans split over spending
Fiscal hawks are demanding deeper cuts on major tax, energy and healthcare package that would advance key Trump administration priorities.
Stocks making the biggest moves premarket: Pinterest, Lyft, Coinbase, BP, Affirm and more
These are the stocks posting the largest moves in premarket trading.
SoftBank posts surprise loss in third quarter, revenue also misses estimates
SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company’s revenue also missed analysts’ estimates.